These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The rehabilitation of thalidomide. MacDougall DS J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029 [TBL] [Abstract][Full Text] [Related]
9. Review of thalidomide use in the pediatric population. Yang CS; Kim C; Antaya RJ J Am Acad Dermatol; 2015 Apr; 72(4):703-11. PubMed ID: 25617013 [TBL] [Abstract][Full Text] [Related]
10. Current role of thalidomide in cancer treatment. Thomas DA; Kantarjian HM Curr Opin Oncol; 2000 Nov; 12(6):564-73. PubMed ID: 11085456 [TBL] [Abstract][Full Text] [Related]
11. [Thalidomide once more in the spotlight]. Bronner GM; Koks CH; Beijnen JH Ned Tijdschr Geneeskd; 1999 Jan; 143(2):122. PubMed ID: 10086119 [No Abstract] [Full Text] [Related]
12. Thalidomide use is associated with weight gain in HIV-1-positive clients. Sharp M; Getty J; Klausner JD J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):392. PubMed ID: 9342262 [No Abstract] [Full Text] [Related]
13. Thalidomide makes a comeback. Dodd-Butera T; Broderick M RN; 2003 May; 66(5):32-5; quiz 36. PubMed ID: 12778690 [No Abstract] [Full Text] [Related]
14. Thalidomide. A surprising recovery. Stirling D; Sherman M; Strauss S J Am Pharm Assoc (Wash); 1997; NS37(3):306-13. PubMed ID: 9170807 [TBL] [Abstract][Full Text] [Related]
15. [Current therapeutic indications of thalidomide and lenalidomide]. Ordi-Ros J; Cosiglio FJ Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554 [TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous ulceration following treatment with thalidomide for GVHD. Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398 [TBL] [Abstract][Full Text] [Related]
18. [Thalidomide: new uses for an old drug]. Wu KL; Sonneveld P Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008 [TBL] [Abstract][Full Text] [Related]
19. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]